Carboplatin and paclitaxel with or without bevacizumab in treating patients with stage III or stage IV ovarian epithelial, primary peritoneal cancer, or fallopian tube cancer

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00262847?term=GOG-0218&rank=1

2. Intervention

   Bevacizumab

3. Resource Description

   Most women with ovarian cancer are not diagnosed until the cancer has spread to the peritoneum (the lining of the abdominal cavity) or beyond. The standard treatment for advanced ovarian cancer is surgery, both to establish the stage and type of cancer and to remove as much cancerous tissue as possible, followed by chemotherapy with drugs such as carboplatin and paclitaxel. Despite aggressive treatment, however, the survival rate for advanced ovarian cancer remains low. In this trial, women who have undergone initial surgery for ovarian cancer or primary peritoneal cancer (which is biologically similar to ovarian cancer) will receive standard intravenous chemotherapy. Some women will also receive concurrent treatment with a biologic agent called bevacizumab. Bevacizumab blocks the activity of a protein called vascular endothelial growth factor, which helps tumors form new blood vessels needed for continued growth and spread. Following chemotherapy, some of the bevacizumab-treated women will receive additional courses of bevacizumab.

4. Additional Name

   Phase III trial of carboplatin and paclitaxel plus placebo versus carboplatin and paclitaxel plus concurrent bevacizumab followed by placebo, versus carboplatin and paclitaxel plus concurrent and extended bevacizumab, in women with newly diagnosed, previously untreated, suboptimal advanced stage epithelial ovarian, primary peritoneal cancer, or fallopian tube cancer

5. Contact

   Berenberg, Jeffrey

6. PI

   Berenberg, Jeffrey

7. Topic

   peritoneal carcinoma

8. Topic

   fallopian tube cancer

9. Topic

   ovarian cancer

10. Study Population

    Females aged 18 and older with histologically confirmed ovarian epithelial, primary peritoneal, or fallopian tube cancer.

11. Website(s)

    http://www.cancer.gov/clinicaltrials/search/view?cdrid=455114&version=healthprofessional

12. Website(s)

    http://www.clinicaltrials.gov/ct2/show/NCT00262847?term=GOG-0218&rank=1

13. Funded by

    Gynecologic Oncology Group

14. Phase

    Phase 3 clinical trial

15. Performed by

    Clinical Protocol & Data Management Shared Resource